{"id":10577,"date":"2026-01-21T06:27:34","date_gmt":"2026-01-21T00:57:34","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&#038;p=10577"},"modified":"2026-01-26T14:42:11","modified_gmt":"2026-01-26T09:12:11","slug":"imdelltra-tarlatamab-dlle","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/imdelltra-tarlatamab-dlle\/","title":{"rendered":"IMDELLTRA (tarlatamab-dlle) for injection"},"content":{"rendered":"<p><strong>Tarlatamab, sold under the brand name Imdelltra, is an anti-cancer medication used for the treatment of extensive-stage small cell lung cancer.<\/strong> It is a bispecific T-cell engager that binds delta-like ligand 3 and CD3. The most common adverse reactions include cytokine release syndrome, fatigue, pyrexia, dysgeusia, decreased appetite, musculoskeletal pain, and constipation, anemia and nausea.<\/p>\n<p>The drug, tarlatamab, is now approved to treat adults whose extensive-stage small cell lung cancer has progressed on or after treatment with platinum-based chemotherapy.<\/p>\n<p>Small cell lung cancer (SCLC) is less common than non-small cell lung cancer, but it is more aggressive, rapidly spreading to other parts of the body. The five-year survival rate for extensive-stage SCLC is 3%,\u00a0according to the American Cancer Society. Second-line treatments for this advanced cancer include more chemotherapy as well as a class of immunotherapies called checkpoint inhibitors, which block proteins that cancers use to evade detection by the immune system.<\/p>\n<h4>Contact IPN \u2013 IMDELLTRA Access in India<\/h4>\n<p><strong>For inquiries regarding availability, import process, or cost of IMDELLTRA (tarlatamab-dlle):<\/strong><br \/>\n<strong>India Pharma Network (IPN)<\/strong> : Headquartered in <strong>New Delhi<\/strong>, with branch offices in <strong>Delhi, Gurugram, Mumbai, Bangalore, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur <\/strong>and<strong> Lucknow<\/strong>, IPN supports medicine imports across India on a <strong>Named Patient Import Basis<\/strong> and for <strong>personal use only<\/strong>.\u00a0<strong>Mobile\/WhatsApp:<\/strong> Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.<strong> Email:<\/strong> <a href=\"mailto:info@indianpharmanetwork.co.in\" target=\"_blank\" rel=\"noopener\">info@indianpharmanetwork.co.in<\/a><\/p>\n<p>NEWS\/UPDATES<\/p>\n<ul>\n<li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-traditional-approval-tarlatamab-dlle-extensive-stage-small-cell-lung-cancer\" target=\"_blank\" rel=\"noopener\">FDA grants traditional approval to tarlatamab-dlle for extensive stage small cell lung cancer.<\/a><\/li>\n<li><a href=\"https:\/\/www.amgen.com\/newsroom\/press-releases\/2025\/11\/fda-grants-full-approval-to-amgens-imdelltra-in-extensive-stage-small-cell-lung-cancer\" target=\"_blank\" rel=\"noopener\">FDA GRANTS FULL APPROVAL TO AMGEN&#8217;S IMDELLTRA\u00ae IN EXTENSIVE STAGE SMALL CELL LUNG CANCER.<\/a><\/li>\n<li><a href=\"https:\/\/www.oncologynewscentral.com\/drugs\/info\/fda-approves-tarlatamab-for-small-cell-lung-cancer\" target=\"_blank\" rel=\"noopener\">FDA Approves Tarlatamab for Small Cell Lung Cancer.<\/a><\/li>\n<li><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2502099\" target=\"_blank\" rel=\"noopener\">Tarlatamab in Small-Cell Lung Cancer after Platinum-Based ChemotherapyA review of FDA approved.drugs and their formulations for the treatment of breast cancer.<\/a><\/li>\n<\/ul>\n<h5>Compliance &amp; Disclaimer<\/h5>\n<p>India Pharma Network acts solely as a facilitator for IMDELLTRA (tarlatamab-dlle) access. IPN does not manufacture, sell, or promote medicines and does not provide medical advice. All imports are:<\/p>\n<ul>\n<li>Strictly on a Named Patient Import Basis<\/li>\n<li>Exclusively for personal use<\/li>\n<li>Not for resale, distribution, or commercial sale<\/li>\n<li>Subject to applicable Indian laws and regulatory approvals<\/li>\n<\/ul>\n<p>The prescribing physician remains solely responsible for dosage, therapy, and clinical decisions.<\/p>\n","protected":false},"excerpt":{"rendered":"<h2>IMDELLTRA (tarlatamab-dlle) \u2013 Lung Cancer Therapy in India<\/h2>\n<p>It is indicated for treating adults with extensive-stage small cell lung cancer (ES-SCLC) whose disease progressed after or during platinum-based chemotherapy, functioning as a bispecific T-cell engager to target DLL3-expressing cancer cells. It&#8217;s approved under accelerated FDA approval, with ongoing trials to confirm clinical benefit.<\/p>\n<table border=\"1\" width=\"95%\">\n<tbody>\n<tr>\n<td><strong>Brand Name:<\/strong><\/td>\n<td>IMDELLTRA<\/td>\n<\/tr>\n<tr>\n<td><strong>Generic Name:<\/strong><\/td>\n<td>tarlatamab-dlle for injection<\/td>\n<\/tr>\n<tr>\n<td><strong>Strength:<\/strong><\/td>\n<td>\u2022 For injection: 1 mg of lyophilized powder in a single-dose vial for<br \/>\nreconstitution and further dilution.<br \/>\n\u2022 For injection: 10 mg of lyophilized powder in a single-dose vial for<br \/>\nreconstitution and further dilution.<\/td>\n<\/tr>\n<tr>\n<td><strong>Manufacturer:<\/strong><\/td>\n<td>Amgen Inc<\/td>\n<\/tr>\n<tr>\n<td><strong>Approved By:<\/strong><\/td>\n<td>EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source Details:\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761344s000lbl.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Patient Information<\/strong>.<\/a><br \/>\n<strong><em>IMDELLTRA must always be used under the supervision of a Registered Medical Practitioner (RMP).<\/em><\/strong><\/p>\n<h3>Access IMDELLTRA for Lung Cancer on a Named Patient Import Basis<\/h3>\n<p><strong>IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to IMDELLTRA (tarlatamab-dlle) For Injection for personal use. <\/strong>To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).<\/p>\n<p><strong>For any queries, including information regarding the cost of the pharmaceutical product in India<\/strong>, please contact the IPN Healthcare Support Team via email or at the following numbers: <strong>Mobile\/WhatsApp:<\/strong> Mr. Tarun: +91 9891 296 838 | \u00a0Mr. Neeraj: +91 9811 747 774.<\/p>\n<p><em><strong>Note:<\/strong> All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.<\/em><\/p>\n","protected":false},"featured_media":10587,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[170,160],"product_tag":[],"class_list":{"0":"post-10577","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-lung","7":"product_cat-solid-tumors","9":"first","10":"instock","11":"shipping-taxable","12":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/10577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/10587"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=10577"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=10577"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=10577"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=10577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}